PLAINSBORO, N.J., Jan. 4, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Friday, February 29, 2008 to discuss financial results for the fourth quarter and full year ended December 31, 2007 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2007 will be announced via a news release issued before the market opens on February 29, 2008.

The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.

Access to the live call is available by dialing 719-325-4774 or through a webcast via a link provided on the Investor Relations homepage of Integra's website at Access to a replay is available through March 14, 2008 by dialing 719-457-0820 (PIN 9005480) or through the webcast.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (


Integra LifeSciences Holdings Corporation
John B. Henneman III, Executive Vice President, 
 Chief Administrative Officer, and Acting Chief 
 Financial Officer
  (609) 936-2481
Karen Mroz-Bremner, Manager, Corporate Development
 and Investor Relations
  (609) 936-6929